Company intelligence / Profile preview

NAP

Khlong Luang, Pathum Thani, Thailand

Ownership: Private
Employees: ~50
Development stage: Other

Overview

NAP Biotech is a Thailand-based biotechnology company specializing in the extraction and development of high-purity natural active products (NAPs) from herbal sources. The company utilizes advanced supercritical CO2 extraction technology to produce premium ingredients for the pharmaceutical, nutraceutical, and cosmetic industries. Their portfolio includes standardized extracts of cannabis, kratom, and various traditional Thai herbs, focusing on therapeutic areas such as pain management and general wellness. As a vertically integrated player, NAP Biotech provides both proprietary product development and contract manufacturing services (CMO) to global partners.

Therapeutic areas: ImmunologyNeurologyOther
Modalities: Small moleculeNatural products
Industry: Biotech

Partnerships

InnoSpace (Thailand)Various Thai academic institutions

Beyond the preview

Go deeper on NAP.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on NAP.

Explore the full profile